Selected data models

You must log in to select data models for download or further analysis.

3 Search results.
Relevance Rating New first Old first

Surveillance of healthcare associated infection: Staphylococcus aureus bacteraemia DSS Metadata Online Registry (METeOR)

- 7/24/16 - 1 form, 14 itemgroups, 26 items, 1 language
Itemgroups: Person 1, Person (name), Person 2, Person (address), Address 1, Person 3, Address 2, Episode of admitted patient care, Establishment 1, Person 4, Laboratory, Patient episode of Staphylococcus aureus bacteraemia, Methicillin-resistant Staphylococcus aureus isolate, Establishment 2
Health sector data set specifications from METeOR, Australia's repository for national metadata standards, developed by the Australian Institute of Health and Welfare (http://meteor.aihw.gov.au/content/index.phtml/itemId/345165) Surveillance of healthcare associated infection: Staphylococcus aureus bacteraemia DSS The purpose of this data set specification (DSS) is to support a comprehensive surveillance program of healthcare associated infections (HAI). HAIs are those infections that are not present or incubating at the time of admission to a healthcare program or facility, develop within a healthcare organisation or are produced by micro-organisms acquired during admission. This DSS is intended to support Staphylococcus aureus bacteraemia (SAB) surveillance in Australian hospitals. It is designed for the purposes of HAI surveillance, not diagnosis. The value of surveillance as part of a hospital infection control program is supported by high-grade international and national evidence. This DSS supports development of local forms and systems for surveillance of HAIs and associated data collection. This DSS applies to patient episodes of SAB in Australian hospitals. Case Definition – Healthcare associated Staphylococcus aureus bacteraemia (SAB) A patient-episode of Staphylococcus aureus bacteraemia (SAB) is a positive blood culture for Staphylococcus aureus. For surveillance purposes, only the first isolate per patient is counted, unless at least 14 days has passed without a positive culture, after which an additional episode is recorded. A SAB will be considered to be a healthcare-associated event if: EITHER • CRITERION A. The patient’s first SAB positive blood culture was collected more than 48 hours after hospital admission or less than 48 hours after discharge. OR • CRITERION B. The patient’s first positive SAB blood culture was collected less than or equal to 48 hours after hospital admission and one or more of the following key clinical criteria was met for the patient-episode of SAB: 1. SAB is a complication of the presence of an indwelling medical device (e.g. intravascular line, haemodialysis vascular access, CSF shunt, urinary catheter) 2. SAB occurs within 30 days of a surgical procedure where the SAB is related to the surgical site 3. SAB was diagnosed within 48 hours of a related invasive instrumentation or incision 4. SAB is associated with neutropenia (Neutrophils: less than 1 x 109/L) contributed to by cytotoxic therapy In order for jurisdictions and private hospital ownership groups to accurately report and monitor Healthcare Associated Infections, the data elements listed should be collected at hospital level for each patient-episode of Staphylococcus aureus bacteraemia. HAI patient episode data elements for SAB, by short name Data elements to be collected for each patient episode Data elements used for calculation of SAB rates Person identifier Patient days Family name Patient episodes of healthcare associated SAB Given name(s) Indigenous status Date of birth Sex Address line (person) Suburb/town/locality name (person) Australian state/territory identifier Australian postcode (address) Admission date Separation date Ward/clinical area Specimen collection date Specimen collection time Laboratory number Specimen identifier Laboratory result identifier Healthcare associated SAB clinical criteria Staphylococcus aureus bacteraemia status SAB methicillin susceptibility Antibiotic susceptibility (MRSA isolate) Antibiotic susceptibility indicator (MRSA isolate) Establishment number © Australian Institute of Health and Welfare 2015 Metadata and Classifications Unit Australian Institute of Health and Welfare GPO Box 570 Canberra ACT 2601

Fluticasone Furoate GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder alone in the treatment of persistent asthma NCT01165138 - Medical Conditions, Family History, Disease Duration, Vital Signs, Candidiasis Examination, Electronically Transferred Lab Data - Screening

- 11/21/18 - 1 form, 11 itemgroups, 34 items, 1 language
Itemgroups: Medical Conditions - Cardiac Disorders, Medical Conditions - Endocrine Disorders, Medical Conditions - Eye Disorders, Medical Conditions - Vascular Disorders, Medical Conditions - Metabolism and Nutrition Disorders, Medical Conditions - Infections and Infestations, Family History, Disease Duration, Vital Signs, Candidiasis Examination, Electronically transferred lab data
Study ID: 106827 Clinical Study ID: HZA106827 Study Title: HZA106827:A randomised, double-blind, placebo-controlled (with rescue medication), parallel group multicentre study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder alone in the treatment of persistent asthma in adults and adolescents Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01165138 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Allermist,Veramyst,Avamys; Relvar Study Indication: Asthma

NO MS InfektionenWund Sub MS University Hospital Muenster (UKM) Subform

- 10/25/16 - 1 form, 4 itemgroups, 27 items, 2 languages
Itemgroups: wound infection, Oberflächliche postoperative Wundinfektion, Tiefe postoperative Wundinfektion, Infektion von Räumen und Organen im Operationsgebiet
Hospital Routine Documentation Subform at the University Hospital Muenster. Original Form name: NO MS InfektionenWund Sub.

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial